SG Americas Securities
AVEO

SG Americas Securities’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

SG Americas Securities’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,047
Closed -$50K – 3617
2019
Q1 		$50K Buy
+6,047
New +$62.4K ﹤0.01% 3194
2018
Q3 		– Sell
-1,098
Closed -$25K – 3610
2018
Q2 		$25K Sell
1,098
-111
-9% -$2.63K ﹤0.01% 3233
2018
Q1 		$35K Sell
1,209
-587
-33% -$17.2K ﹤0.01% 3122
2017
Q4 		$50K Buy
+1,796
New +$55.8K ﹤0.01% 2976
2014
Q2 		– Sell
-3,476
Closed -$52K – 2781
2014
Q1 		$52K Buy
+3,476
New +$62.4K ﹤0.01% 2310
2013
Q4 		– Sell
-1,168
Closed -$24K – 3165
2013
Q3 		$24K Buy
+1,168
New +$26.7K ﹤0.01% 2882

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

SG Americas Securities's AVEO Position: Q2 2019 in Review

SG Americas Securities sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2019, closing a stake of 6,047 shares — an estimated $50K sold.

SG Americas Securities first reported a position in AVEO in Q3 2013 and held it in 6 quarters. The position peaked at $52K in Q1 2014. 73 funds tracked by Wall St. Rank hold AVEO as of Q2 2019.

  • SG Americas Securities reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • SG Americas Securities sold 6,047 AVEO Pharmaceuticals, Inc. shares in Q2 2019, an estimated $50K.
  • SG Americas Securities first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2013 and held it in 6 quarters.
  • SG Americas Securities's AVEO Pharmaceuticals, Inc. position peaked at $52K in Q1 2014.
  • 73 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2019.

Based on SG Americas Securities's 13F filing for Q2 2019, filed 29 Jul 2019.